Re: Managing hyperglycaemia during antenatal steroid administration, labour and birth in pregnant women with diabetes – An updated guideline from the Joint British Diabetes Society...

por Rowe, Christopher W., Wynne, Katie
Publicado 2022

MON-535 Deep-Machine Learning for Objective Quantification of Nerves in Immunohistochemistry Specimens of Thyroid Cancer

por Astono, Indriani, Rowe, Christopher W, Welsh, James, Jobling, Phillip
Publicado 2020

Objective quantification of nerves in immunohistochemistry specimens of thyroid cancer utilising deep learning

por Astono, Indriani P., Welsh, James S., Rowe, Christopher W., Jobling, Phillip
Publicado 2022

Management of metastatic thyroid cancer in pregnancy: risk and uncertainty

por Rowe, Christopher W, Murray, Kirsten, Woods, Andrew, Gupta, Sandeep, Smith, Roger, Wynne, Katie
Publicado 2016

SAT-427 Quality of Life Following Treatment for Graves’ Disease: A Comparison of Radioactive Iodine Ablation and Surgery

por Rowe, Christopher W, Blefari, Nicholas D, Rutherford, Natalie, Bendinelli, Cino, O’Neill, Chris
Publicado 2020

Castration failure in prostate carcinoma due to a functioning adrenocortical carcinoma

por Navani, Vishal, Lynam, James F, Smith, Steven, O’Neill, Christine J, Rowe, Christopher W
Publicado 2021

Variability in Thyroid Cancer Multidisciplinary Team Meeting Recommendations Is Not Explained by Standard Variables: Outcomes of a Single Centre Review

por Fenton, Mark E., Wade, Sarah A., Pirrili, Bibi N., Balogh, Zsolt J., Rowe, Christopher W., Bendinelli, Cino
Publicado 2021

Current patterns of care in low‐risk thyroid cancer—A national cross‐sectional survey of Australian thyroid clinicians

por Widjaja, Winy, Rowe, Christopher W., Oldmeadow, Christopher, Cope, Daron, Fradgley, Elizabeth A., Paul, Christine, O'Neill, Christine J.
Publicado 2023

Adoption of a pregnancy‐specific intravenous insulin protocol (Pregnancy‐IVI) at a regional centre has equivalent safety and efficacy outcomes as a tertiary hospital

por Rowe, Christopher W., Qiao, Vivian, Ramesh, Soundarya, Rosee, Patrick, Sathiakumar, Angeline, McWhae‐Brown, Sienna, Griffiths, Eliza, Wynne, Katie
Publicado 2022

Innervation of papillary thyroid cancer and its association with extra-thyroidal invasion

por Rowe, Christopher W., Dill, Tony, Griffin, Nathan, Jobling, Phil, Faulkner, Sam, Paul, Jonathan W., King, Simon, Smith, Roger, Hondermarck, Hubert
Publicado 2020

Nerve growth factor and its receptor tyrosine kinase TrkA are overexpressed in cervical squamous cell carcinoma

por Faulkner, Sam, Griffin, Nathan, Rowe, Christopher W., Jobling, Phillip, Lombard, Janine M., Oliveira, Sonia M., Walker, Marjorie M., Hondermarck, Hubert
Publicado 2020

Long-Term Health-Related Quality of Life Outcomes Following Thyroid Surgery for Malignant or Benign Disease: Deficits Persist in Cancer Survivors Beyond Five Years

por Blefari, Nicholas D. A., Rowe, Christopher W., Wiadji, Elvina, Lambkin, David, Carroll, Rosemary, Fradgley, Elizabeth A., O’Neill, Christine J.
Publicado 2022

The Precursor for Nerve Growth Factor (proNGF) in Thyroid Cancer Lymph Node Metastases: Correlation with Primary Tumour and Pathological Variables

por Rowe, Christopher W., Dill, Tony, Faulkner, Sam, Gedye, Craig, Paul, Jonathan W., Tolosa, Jorge M., Jones, Mark, King, Simon, Smith, Roger, Hondermarck, Hubert
Publicado 2019

The neurotrophic tyrosine kinase receptor TrkA and its ligand NGF are increased in squamous cell carcinomas of the lung

por Gao, Fangfang, Griffin, Nathan, Faulkner, Sam, Rowe, Christopher W., Williams, Lily, Roselli, Severine, Thorne, Rick F., Ferdoushi, Aysha, Jobling, Phillip, Walker, Marjorie M., Hondermarck, Hubert
Publicado 2018

The precursor for nerve growth factor (proNGF) is not a serum or biopsy-rinse biomarker for thyroid cancer diagnosis

por Rowe, Christopher W., Faulkner, Sam, Paul, Jonathan W., Tolosa, Jorge M., Gedye, Craig, Bendinelli, Cino, Wynne, Katie, McGrath, Shaun, Attia, John, Smith, Roger, Hondermarck, Hubert
Publicado 2019